Search research articles
Contact Us
Filters
Showing results (281-290 of 312) with videos related to
Page
of 32
Sort By:
Journal of Endourology
|
July 26, 2000
Minimally invasive treatment for localized adenocarcinoma of the prostate: review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy
J Sharkey, S D Chovnick, R J Behar, et al.
Fortschritte Der Neurologie-Psychiatrie
|
April 17, 2013
Management and outcome of pallidal deep brain stimulation in severe Huntington's disease
D Huys, C Bartsch, P Poppe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 30, 2010
Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice
Erin E Mulvihill, Julia M Assini, Brian G Sutherland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2015
Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling
Jacob S Bowers, Michelle H Nelson, Sreenath Kundimi, et al.
Journal of Lipid Research
|
February 4, 2003
Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB
Dawn E Telford, Jane Y Edwards, Sara M Lipson, et al.
Diabetes
|
July 14, 2009
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance
Erin E Mulvihill, Emma M Allister, Brian G Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 15, 2014
G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies
Yasin Hussain, Qingming Ding, Philip W Connelly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 8, 2005
A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content
Dawn E Telford, Sara M Lipson, P Hugh R Barrett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 4, 2017
Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in <i>Ldlr</i> Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid
Joshua P Samsoondar, Amy C Burke, Brian G Sutherland, et al.
Human Molecular Genetics
|
July 4, 2008
Polygenic determinants of severe hypertriglyceridemia
Jian Wang, Matthew R Ban, Guang Yong Zou, et al.
Page
of 32
Search research articles
Search
Showing results (281-290 of 312) with videos related to
Sort By:
Page
of 32
Journal of Endourology
|
July 26, 2000
Minimally invasive treatment for localized adenocarcinoma of the prostate: review of 1048 patients treated with ultrasound-guided palladium-103 brachytherapy
J Sharkey, S D Chovnick, R J Behar, et al.
Fortschritte Der Neurologie-Psychiatrie
|
April 17, 2013
Management and outcome of pallidal deep brain stimulation in severe Huntington's disease
D Huys, C Bartsch, P Poppe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 30, 2010
Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice
Erin E Mulvihill, Julia M Assini, Brian G Sutherland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2015
Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling
Jacob S Bowers, Michelle H Nelson, Sreenath Kundimi, et al.
Journal of Lipid Research
|
February 4, 2003
Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB
Dawn E Telford, Jane Y Edwards, Sara M Lipson, et al.
Diabetes
|
July 14, 2009
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance
Erin E Mulvihill, Emma M Allister, Brian G Sutherland, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 15, 2014
G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies
Yasin Hussain, Qingming Ding, Philip W Connelly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 8, 2005
A novel inhibitor of oxidosqualene:lanosterol cyclase inhibits very low-density lipoprotein apolipoprotein B100 (apoB100) production and enhances low-density lipoprotein apoB100 catabolism through marked reduction in hepatic cholesterol content
Dawn E Telford, Sara M Lipson, P Hugh R Barrett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
February 4, 2017
Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in <i>Ldlr</i> Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid
Joshua P Samsoondar, Amy C Burke, Brian G Sutherland, et al.
Human Molecular Genetics
|
July 4, 2008
Polygenic determinants of severe hypertriglyceridemia
Jian Wang, Matthew R Ban, Guang Yong Zou, et al.
Page
of 32